Other research indicates that reducing IL-33 concentrations in mouse models of ALI/ARDS can control lung inflammation by inducing a Th17 response, affecting the Th17/Treg balance, and regulating autophagy, thereby improving prognosis [50,51]. Here, IL33 is linked to acute respiratory distress syndrome.